TAKROZEM

This brand name is authorized in Austria, Spain, France, Italy, Netherlands

Active ingredients

The drug TAKROZEM contains one active pharmaceutical ingredient (API):

1 Tacrolimus monohydrate UNII WM0HAQ4WNM - TACROLIMUS

Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor. Read about Tacrolimus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D11AH01	Tacrolimus	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AH Agents for dermatitis, excluding corticosteroids
Discover more medicines within D11AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 82701
Country: FR	Base de données publique des médicaments	Identifier(s): 66080171
Country: IT	Agenzia del Farmaco	Identifier(s): 044064044, 044064057
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 67652